Stock·NYSE·Technology
UiPath, Inc. (PATH)
- Market cap
- $7.15B
- P/E
- 19.79
- Dividend yield
- 0.00%
- Street target
- $15.00median of 21 analysts
- 52-week range
- $9.20 $19.84
The short version
Where PATH stands today, in four lines, and what CleaRank Financial AI makes of it.
PATH at a glance
UiPath, Inc. (PATH): Hold, 50/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($12.54 and $14.71).
- Earnings PATH beat estimates in 6 of its last 8 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $139.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 19.8 against 35.1 for the Technology sector: a discount to peers (-44%).
Figures as of October 16, 2026.
CleaRank Financial AI
UiPath, Inc. (PATH) is currently trading at $13.71, below its 50-day simple moving average of $14.71, indicating some near-term technical weakness.
The company operates in the Software - Infrastructure industry within the Technology sector, an area that has seen median revenue growth of 24.2%. UiPath's own fundamentals show a healthy profit margin of 21.03% and a low debt-to-equity ratio of 0.04, but its price-to-sales ratio of 3.96 is below the sector median of 7.6. The stock's performance is currently being weighed down by significant insider selling, with over $139.5 million in sales reported, contributing to a 'Heavy Sell Signal' verdict from insider activity analysis.
Only on CleaRank
Figures we compute ourselves from PATH's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $13.71 is 6.8% below the 50-day simple moving average of $14.71.Price above its 200-day average ›
The price is 9.4% above the 200-day simple moving average of $12.54.50-day average above the 200-day ›
The 50-day average ($14.71) is 17.4% above the 200-day average ($12.54), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 42% of its 52-week range, between $9.20 and $19.84.
PATH share price
Pick a period: each tab shows how far PATH has moved over it, to the last close.
Today's trading
Where PATH sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/4P/E below the sector median ›
The trailing P/E of 19.79 is 43.6% below the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 3.96 is 48.0% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $361.9M on revenue of $1.7B, a net margin of 21.0%.Beat estimates in most recent reports ›
PATH beat the EPS estimate in 6 of its last 8 reports.
Key statistics
The headline figures for PATH.
As of October 16, 2026, PATH trades at $13.71, with a market value of $7.15B and a P/E ratio of 19.79.
What the numbers say
CleaRank Financial AI's reading of PATH's valuation, growth and risks.
UiPath's valuation appears reasonable when compared to its sector averages, with a P/E ratio of 19.79 and a price-to-sales ratio of 3.96, both below the sector medians of 35.1 and 7.6 respectively.
The company demonstrates strong profitability with a net profit margin of 21.03% and a return on equity of 20.03%. Its balance sheet is strong, evidenced by a low debt-to-equity ratio of 0.04. Despite these solid fundamentals, the significant insider selling activity raises concerns about management's near-term outlook for the stock.
PATH against the Technology sector
How PATH compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: PATH trades at a notable discount to sector peers (-44%), which may indicate undervaluation or specific company headwinds.
Return vs XLK: Since May 5, 2025, PATH has gained 16.5% against a gain of 75.6% for XLK.
Performance against XLK
PATH and the Technology sector fund over the same days.
Revenue and earnings
How much PATH sells, and how much of it becomes profit.
Revenue growth: Revenue grew 12.7% in FY2026 to $1.6B, from $1.4B a year earlier.
Profit margin: The net margin was 17.5% in FY2026, up from -5.2% the year before.
Profitable: PATH earned $282M in FY2026.
Earnings reality check
Did PATH beat what analysts expected, and how did the stock react?
Earnings record: PATH beat the analyst estimate in 6 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Sep 3, 2026after close | $0.15 | $0.15 | +0.00% | -16.63% | -24.53% |
| May 28, 2026after close | $0.16 | $0.15 | -6.25% | +1.21% | +0.78% |
| Mar 11, 2026after close | $0.25 | $0.30 | +20.00% | -8.16% | +0.57% |
| Dec 3, 2025after close | $0.15 | $0.16 | +6.67% | +24.36% | +25.77% |
| Sep 4, 2025after close | $0.08 | $0.15 | +87.50% | +5.90% | +7.74% |
| May 29, 2025after close | $0.10 | $0.11 | +10.00% | +2.86% | +2.47% |
| Mar 12, 2025after close | $0.19 | $0.26 | +36.84% | -15.72% | -8.71% |
| Dec 5, 2024after close | $0.07 | $0.11 | +57.14% | -0.94% | -4.82% |
As of October 16, 2026, PATH has beaten the analyst EPS estimate in 6 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on September 3, 2026, came in 0.00% above the estimate and the stock moved -16.63% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 51.7, in neutral territory.RSI above 50 ›
An RSI of 51.7 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of PATH
The score, the reasoning behind it, and what could move the price next.
UiPath's stock is trading below its 50-day simple moving average of $14.71, though it remains above its 200-day simple moving average at $12.54.
The 14-day RSI is at 51.72, indicating neutral momentum. The 20-day exponential moving average is at $13.42, with the price currently trading above it. Volume on the latest trading day was 32.1 million shares, which is 25.9% above the average volume, suggesting increased investor interest. The stock's positioning relative to its moving averages suggests a mixed technical picture, with the 50-day SMA acting as near-term resistance.
Strong Profitability and Low Debt ›
UiPath maintains a healthy profit margin of 21.03% and a very low debt-to-equity ratio of 0.04, providing a solid financial foundation.
Source: Company FundamentalsMixed Analyst Ratings ›
Wall Street analysts hold a predominantly 'Hold' rating, with a median price target of $15.00, suggesting limited immediate upside potential.
Source: Wall Street Summary
Heavy Insider Selling Pressure ›
Insiders have sold over $139.5 million worth of stock, leading to a 'Heavy Sell Signal' and raising concerns about management's confidence.
Source: Insider Transaction DataRecent Earnings Report Impact ›
The earnings report on September 3, 2026, resulted in a -16.63% price change, indicating negative market reaction to the latest financial results.
Source: Earnings Data
- Monitor upcoming earnings reports closely, especially the revenue growth figures, as the current quarter's projected growth is +8.00% YoY.
- The stock is trading below its 50-day SMA, suggesting potential for further short-term weakness. A move back above this level would be a positive technical signal.
Technical indicators
Momentum and trend for PATH, from its daily closes.
As of October 16, 2026, with PATH at $13.71, its 14-day RSI is 51.7 (neutral territory), its 50-day simple moving average is $14.71 and its 200-day is $12.54.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What PATH moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, PATH's 1-year correlation of daily returns is +0.38 with S&P 500 (SPY), +0.36 with Nasdaq 100 (QQQ), +0.19 with Bitcoin (BTC) and +0.02 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
3 of 21 analysts rate it a buy or strong buy, 16 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $15.00 is 9.4% above the price.More buy ratings than three months ago ›
3 of 21 rate it a buy now, against 3 of 20 three months ago.
PATH Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 28, 2026 | DA Davidson | Downgrade | Underperform |
| Sep 25, 2026 | UBS | Maintains | Neutral |
| Sep 24, 2026 | BMO Capital | Maintains | Market Perform |
| Sep 24, 2026 | Canaccord Genuity | Maintains | Hold |
| Sep 24, 2026 | TD Cowen | Maintains | Hold |
| Sep 23, 2026 | Truist Securities | Maintains | Hold |
As of October 16, 2026, 21 Wall Street analysts cover PATH: 3 rate it a buy or strong buy, 16 a hold and 2 a sell or strong sell. Their 12-month price targets range from $10.00 to $23.00, with a median of $15.00, 9.4% above the price of $13.71.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
PATH trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
PATH moves about 4.2% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much PATH tends to move, against the market and on its own.
The long record
PATH's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 4.17% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 89.0%, from May 2021 to April 2026; the price is still 83.9% below that peak.Most 1-year holds ended higher ›
32% of 1-year holding periods in the last 5 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in April 2021 is now worth $1,986.96, against $19,956 in the S&P 500 (SPY).
PATH Drawdowns & Recovery
As of October 16, 2026, PATH's worst peak-to-trough fall over the last 5 years with dividends reinvested was -89.0% (May 2021 to April 2026); it is still 83.9% below that peak, and 32% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into PATH in April 2021 is worth now, against the same amount in the S&P 500.
Against the market: PATH trailed the S&P 500 over this period: $1,986.96 against $19,956.
A $10,000 investment in PATH in April 2021 would be worth about $1,987 today with dividends reinvested, compared with about $19,956 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to PATH, and which have not.
Strongest month, December: an average of +8.01%, up in 2 of 5 years.
Weakest month, April: an average of -9.96%, up in 1 of 5 years.
This month, October: has averaged +4.81%, up in 2 of 5 years. Past seasonality does not repeat on schedule.
Over the last 6 years, PATH's strongest calendar month has been December (average +8.01%, up in 2 of 5 years) and its weakest April (average -9.96%, up in 1 of 5 years).
Average return for each calendar month over the last 6 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in PATH, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in PATH today could grow to about $3,810 by 2036 in the base case, with a 90th-percentile outcome near $28,907 and a 10th-percentile outcome around $502. Projections are statistical simulations, not guarantees.
PATH Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $9.32 for PATH by 2030 in the base case, from $13.71 today (0.7x over 4 years). The 10th-percentile path ends near $2.59. These are outcomes of a Monte Carlo simulation run on PATH's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $6.56 | $12.45 | $23.63 | |
| 2028 | $4.57 | $11.30 | $27.98 | |
| 2029 | $3.38 | $10.26 | $31.14 | |
| 2030 | $2.59 | $9.32 | $33.57 | |
| 2031 | $2.02 | $8.46 | $35.46 |
Method: a lognormal simulation of PATH's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
PATH insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought PATH shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, PATH insiders reported 130 open-market sales worth $139.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Ashim A Gupta
Chief Operating Officer
|
Sell | 66.1K | $869.8K |
| Sep 17, 2026 | Raghavendra Malpani
Chief Technology Officer
|
Sell | 40.5K | $566.6K |
| Sep 16, 2026 | Raghavendra Malpani
Chief Technology Officer
|
Sell | 98.4K | $1.4M |
| Sep 11, 2026 | Ashim A Gupta
Chief Operating Officer
|
Sell | 117.3K | $1.6M |
| Sep 8, 2026 | Daniel Dines
Chief Executive Officer
|
Grant | 5.0M | - |
| Sep 3, 2026 | Brad C Brubaker
Officer
|
Grant | 300.0K | - |
| Sep 3, 2026 | Ashim A Gupta
Chief Operating Officer
|
Grant | 1.1M | - |
| Sep 3, 2026 | Raghavendra Malpani
Chief Technology Officer
|
Grant | 1.1M | - |
| Sep 3, 2026 | Hitesh Ramani
Chief Financial Officer
|
Grant | 655.4K | - |
| Aug 19, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 1.4M | $22.5M |
| Aug 14, 2026 | Hitesh Ramani
Officer
|
Sell | 50.0K | $831.3K |
| Jun 25, 2026 | Philippe Botteri
Director
|
Grant | 19.2K | - |
| Jun 25, 2026 | Michael Lawrence Gordon
Director
|
Grant | 19.2K | - |
| Jun 25, 2026 | Daniel D Springer
Director
|
Grant | 19.2K | - |
| Jun 25, 2026 | Karenann K Terrell
Director
|
Grant | 19.2K | - |
| Jun 25, 2026 | Richard P. Wong
Director
|
Grant | 19.2K | - |
| Jun 25, 2026 | June Yang
Director
|
Grant | 19.2K | - |
| Apr 1, 2026 | Brad C Brubaker
General Counsel
|
Grant | 157.2K | - |
| Apr 1, 2026 | Ashim A Gupta
Chief Operating Officer
|
Grant | 306.7K | - |
| Apr 1, 2026 | Raghavendra Malpani
Chief Technology Officer
|
Grant | 159.1K | - |
| Apr 1, 2026 | Hitesh Ramani
Officer
|
Grant | 123.5K | - |
| Feb 25, 2026 | Brad C Brubaker
General Counsel
|
Grant | 146.0K | - |
| Feb 25, 2026 | Ashim A Gupta
Chief Operating Officer
|
Grant | 288.3K | - |
| Feb 25, 2026 | Hitesh Ramani
Officer
|
Grant | 31.0K | - |
| Jan 26, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 135.0K | $2.0M |
| Jan 15, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $691.9K |
| Jan 14, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $705.6K |
| Jan 13, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $773.2K |
| Jan 12, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $747.4K |
| Jan 9, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $772.7K |
| Jan 8, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $787.2K |
| Jan 7, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $779.3K |
| Jan 6, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $719.7K |
| Jan 5, 2026 | Ashim A Gupta
Chief Operating Officer
|
Sell | 67.5K | $1.1M |
| Jan 5, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $707.9K |
| Jan 2, 2026 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $737.3K |
| Dec 31, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 90.0K | $1.5M |
| Dec 29, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 135.0K | $2.3M |
| Dec 23, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 90.0K | $1.5M |
| Dec 23, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $723.3K |
| Dec 19, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $723.3K |
| Dec 18, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $730.2K |
| Dec 17, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $725.1K |
| Dec 16, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $731.5K |
| Dec 15, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 90.0K | $1.6M |
| Dec 15, 2025 | Daniel Dines
Chief Executive Officer
|
Grant | 9.6M | - |
| Dec 11, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $835.3K |
| Dec 10, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $837.5K |
| Dec 9, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $861.1K |
| Dec 8, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $864.6K |
| Dec 5, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $818.8K |
| Dec 5, 2025 | Brad C Brubaker
General Counsel
|
Sell | 27.6K | $511.7K |
| Nov 5, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $678.4K |
| Nov 4, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $676.1K |
| Nov 3, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $730.2K |
| Oct 31, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $707.3K |
| Oct 30, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $707.6K |
| Oct 29, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 135.0K | $2.3M |
| Oct 24, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $695.6K |
| Oct 23, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $683.3K |
| Oct 22, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $698.9K |
| Oct 22, 2025 | Hitesh Ramani
Officer
|
Sell | 5.0K | $77.3K |
| Oct 21, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $700.6K |
| Oct 21, 2025 | Hitesh Ramani
Officer
|
Sell | 10.0K | $156.8K |
| Oct 20, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $707.0K |
| Oct 20, 2025 | Hitesh Ramani
Officer
|
Sell | 10.0K | $156.5K |
| Oct 17, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $702.9K |
| Oct 17, 2025 | Hitesh Ramani
Officer
|
Sell | 10.0K | $157.3K |
| Oct 16, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $2.1M |
| Oct 16, 2025 | Hitesh Ramani
Officer
|
Sell | 10.0K | $163.5K |
| Oct 15, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $2.1M |
| Oct 15, 2025 | Brad C Brubaker
General Counsel
|
Sell | 27.6K | $459.9K |
| Oct 15, 2025 | Hitesh Ramani
Officer
|
Sell | 20.0K | $332.2K |
| Oct 14, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 245.5K | $4.1M |
| Oct 13, 2025 | Hitesh Ramani
Officer
|
Sell | 10.0K | $170.1K |
| Oct 10, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $2.3M |
| Oct 9, 2025 | Ashim A Gupta
Chief Operating Officer
|
Sell | 240.9K | $4.2M |
| Oct 9, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $2.0M |
| Oct 9, 2025 | Ashim A Gupta
Chief Operating Officer
|
Option | 148.0K | $111.5K |
| Oct 8, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.8M |
| Oct 7, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.8M |
| Oct 6, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.7M |
| Oct 6, 2025 | Brad C Brubaker
General Counsel
|
Sell | 66.7K | $1,000.0K |
| Oct 3, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.6M |
| Oct 2, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.6M |
| Oct 1, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.6M |
| Sep 30, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.8M |
| Sep 30, 2025 | Brad C Brubaker
General Counsel
|
Sell | 16.1K | $241.3K |
| Sep 29, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.5M |
| Sep 26, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.5M |
| Sep 25, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.5M |
| Sep 24, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.5M |
| Sep 23, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.6M |
| Sep 22, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.5M |
| Sep 19, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.5M |
| Sep 18, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.5M |
| Sep 17, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 122.7K | $1.4M |
| Sep 10, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $540.5K |
| Sep 5, 2025 | Daniel Dines
Chief Executive Officer
|
Grant | 3.1M | - |
| Jul 31, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 10.0K | $119.9K |
| Jul 30, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $542.8K |
| Jul 29, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $548.8K |
| Jul 28, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $547.4K |
| Jul 25, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $551.2K |
| Jul 24, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $564.8K |
| Jul 23, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $565.4K |
| Jul 22, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $561.2K |
| Jul 21, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $572.2K |
| Jul 18, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $557.2K |
| Jul 17, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $560.1K |
| Jul 16, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $559.2K |
| Jul 15, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $562.6K |
| Jul 14, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $559.6K |
| Jul 11, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $572.1K |
| Jul 10, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $587.7K |
| Jul 9, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $592.7K |
| Jul 8, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $594.5K |
| Jul 7, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $590.1K |
| Jul 3, 2025 | Daniel Dines
Chief Executive Officer
|
Sell | 45.0K | $585.6K |
| Jul 2, 2025 | Ashim A Gupta
Chief Operating Officer
|
Sell | 56.3K | $716.5K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.